CDSCO Registered · Made in India
UV therapy that
actually doses
your skin.
UVThera delivers clinically precise 308nm and 311nm UV light for vitiligo, psoriasis, and eczema — the same wavelengths used in leading dermatology clinics, now for your home and practice.
Find My Device I'm a Dermatologist
✔️IIT Bombay developed ✔️308nm & 311nm ✔️Real dosimetry ✔️20,000 hr LED
Conditions we treat
What are you treating?
UV phototherapy is a first-line clinical treatment for several chronic skin conditions.
🔵
Vitiligo
8.8% prevalence in India
Loss of skin pigmentation. UV therapy stimulates melanocyte activity to restore pigmentation over 3–12 months.
🔴
Psoriasis
2–3% of India's population
Chronic inflammatory skin disease. NB-UVB reduces inflammation and slows skin cell proliferation effectively.
🟡
Eczema
~20% lifetime prevalence
Chronic dry, itchy skin. UV therapy modulates the immune response and provides lasting relief for many patients.
🟠
Atopic Dermatitis
Affects 10–20% of children
UV phototherapy is a proven second-line treatment when topical therapies provide insufficient control
Why UVThera is different
Most UV devices time.
UVThera doses.
This is not a minor technical distinction. It is the difference between consistent clinical outcomes and unpredictable results.
Timer-based devices
30 seconds today ≠ 30 seconds in 6 months
A UV tube loses output gradually — around 20% by 1,000 hours. A timer has no way to know this. Your patient receives progressively less therapy as the tube ages, with no indication that the dose has dropped.
Actual UV output varies — but the timer still says 30 seconds.🆚
UVThera dosimetry
Every session delivers exactly what was prescribed
UVThera measures actual UV output at every session using a calibrated photodiode. If tube output drops, the session runs longer to compensate. Your patient always receives the prescribed dose in mJ/cm².
Dose measured and confirmed. Every session. Automatically.Devices
Four devices.
One therapy platform.
All CDSCO registered. All Made in India. All backed by IIT Bombay.
Clinical foundation
30 years of evidence.
One right wavelength.
UVThera is built on the most extensively studied wavelengths in dermatological phototherapy. Not experimental — first-line clinical treatment.
— Scientific advisory
"As both a researcher and someone living with vitiligo, I've seen how inconsistent dosing undermines otherwise good treatment. UVThera is the first home device I trust to deliver what it promises."
Department of Electrical Engineering, IIT Bombay
For dermatologists
Prescribe with
complete confidence.
India's first connected home phototherapy system with real-time dosimetry, ABHA integration, and a clinic dashboard.
📊
Patient dashboard
See all your patients' session logs, dose history, and repigmentation photos from your clinic browser.
🔗
ABHA integrated
Session records link to your patient's ABHA health ID. Treatment history travels with the patient.
💊
Protocol management
Set MED, starting dose, and escalation schedule from your dashboard. The device enforces your protocol.
📱
Demo programme
Registered prescribers receive a clinic demonstration unit at nominal cost.
📋
Clinical evidence
Full clinical dossier, CDSCO registration documents, and IIT Bombay validation reports available.
🇮🇳
Pan-India support
ColMed's 700+ district distribution network provides device support across India.
The UVThera app
Your therapy,
in your hands.
The UVThera app connects to your device via Bluetooth, tracks every session, and keeps you and your dermatologist in sync.
Common questions
Answered honestly.
UVThera Basic and Pro can be purchased without a prescription. However, we strongly recommend consulting a dermatologist before starting UV therapy — your doctor can determine the right starting dose for your skin type and condition.
The key difference is dosimetry. UVThera Basic uses a timer. UVThera Pro measures actual UV output using a photodiode and delivers a precise dose in mJ/cm². As your tube ages, Pro automatically extends sessions to maintain your prescribed dose.
Both are clinically validated for vitiligo and psoriasis. 308nm (Clinical console) shows faster initial repigmentation for targeted spot treatment. 311nm (home devices) has decades of evidence for NB-UVB home phototherapy and is equally effective over a full treatment course.
For vitiligo, most patients see initial repigmentation at 6–12 weeks with consistent treatment (3–5 sessions per week). Significant repigmentation typically takes 3–6 months. Psoriasis typically responds faster — many patients see improvement within 4–6 weeks.
311nm NB-UVB phototherapy has an excellent safety profile with over 30 years of clinical evidence. UVThera devices include UV-blocking quartz windows, safety cutoffs, dose limits, and eye protection guidelines in the IFU.
UVThera Pro tracks lamp hours automatically and alerts you when replacement is approaching (typically at 1,000 hours). The app sends a notification and you can order a replacement tube directly. UVThera Basic recommends replacement at 12–18 months.